1,045 research outputs found

    XXXVI.— Brachiopod nomenclature : Seminula, &c.

    Get PDF
    n/

    Latent variable mixture modelling and individual treatment prediction

    Get PDF
    Understanding which groups of patients are more or less likely to benefit from specific treatments has important implications for healthcare. Many personalised medicine approaches in mental health employ variable-centred approaches to predicting treatment response, yet person-centred approaches that identify clinical profiles of patients can provide information on the likelihood of a range of important outcomes. In this paper, we discuss the use of latent variable mixture modelling and demonstrate its use in the application of a patient profiling algorithm using routinely collected patient data to predict outcomes from psychological treatments. This validation study analysed data from two services, which included n = 44,905 patients entering treatment. There were different patterns of reliable recovery, improvement and clinical deterioration from therapy, across the eight profiles which were consistent over time. Outcomes varied between different types of therapy within the profiles: there were significantly higher odds of reliable recovery with High Intensity therapies in two profiles (32.5% of patients) and of reliable improvement in three profiles (32.2% of patients) compared with Low Intensity treatments. In three profiles (37.4% of patients) reliable recovery was significantly more likely if patients had CBT vs Counselling. The developments and potential application of latent variable mixture approaches are further discussed

    Photodetachment study of He^- quartet resonances below the He(n=3) thresholds

    Get PDF
    The photodetachment cross section of He^- has been measured in the photon energy range 2.9 eV to 3.3 eV in order to investigate doubly excited states. Measurements were made channel specific by selectively detecting the residual He atoms left in a particular excited state following detachment. Three Feshbach resonances were found in the He(1s2p ^3P)+e^-(epsilon p) partial cross section: a ^4S resonance below the He(1s3s ^3S) threshold and two ^4P resonances below the He(1s3p ^3P) threshold. The measured energies of these doubly excited states are 2.959260(6) eV, 3.072(7) eV and 3.26487(4) eV. The corresponding widths are found to be 0.20(2) meV, 50(5) meV and 0.61(5) meV. The measured energies agree well with recent theoretical predictions for the 1s3s4s ^4S, 1s3p^2 ^4P and 1s3p4p ^4P states, respectively, but the widths deviate noticeably from calculations for 1s3p^2 ^4P and 1s3p4p ^4P states.Comment: 10 pages, 3 figures, LaTeX2e scrartcl, amsmath. Accepted by Journal of Physics B; minor changes after referee repor

    Establishing a service improvement network to increase access to care and improve treatment outcomes in community mental health: a series of retrospective cohort studies

    Get PDF

    Elastic Cross Sections for Electron Collisions with Molecules Relevant to Plasma Processing

    Get PDF
    Absolute electron-impact cross sections for molecular targets, including their radicals, are important in developing plasma reactors and testing various plasma processing gases. Low-energy electron collision data for these gases are sparse and only the limited cross section data are available. In this report, elastic cross sections for electron-polyatomic molecule collisions are compiled and reviewed for 17molecules relevant to plasma processing. Elastic cross sections are essential for the absolute scale conversion of inelastic cross sections, as well as for testing computational methods. Data are collected and reviewed for elastic differential, integral, and momentum transfer cross sections and, for each molecule, the recommended values of the cross section are presented. The literature has been surveyed through early 2010.This work is accomplished as a collaboration through APAN (Asia-Pacific Atomic Data Network: a network for dissemination of collisional data relevant to plasmas, discharges, materials, and biosciences). H.C. acknowledges a support by the National Research Foundation of Korea (Grant No. 20100000035), and M.J.B. and S.J.B. support from the Australian Research Council Center of Excellence for Antimatter-Matter Studies. Collaboration between NIFS and NFRI is also acknowledged for the Korea-Japan exchanges

    Trends in depression & anxiety symptom severity among mental health service attendees during the COVID-19 pandemic

    Get PDF
    Background: General population surveys have shown that some groups, particularly young women, experienced increased distress during nationally mandated restrictions to control the spread of COVID-19. However, there has been limited research on such trends among people with pre-existing mental health conditions, leaving mental health services ill equipped to plan for current and future lockdowns. / Methods: Mean weekly scores on the GAD-7 and PHQ-9 between 01/01/2020-22/06/2020 (n=9,538 individuals) for all patients of two psychological treatment services (Improving Access to Psychological Therapies) in London, were compared to mean weekly scores from the same time periods in 2017-2019 (n=37,849). The proportion of scores which were above the clinical thresholds for ‘caseness’ each week were compared, and scores between groups based on gender, age group, and ethnicity, were also compared. / Results: Confirmed community transmission in the UK (26/02/2020-03/03/2020) and the announcement of the national ‘lockdown’ (23/03/2020) were associated with significant increases in anxiety symptom scores. ‘Lockdown’ was associated with a decrease in depression scores. These changes were not maintained during lockdown. Significant increases in depression and anxiety were observed at week 23, as restrictions were eased. / Limitations: This was an exploratory analysis in two services only. Residual confounding and selection biases cannot be ruled out. / Conclusions: Differences in the weekly average symptom scores were short-term; they did not continue throughout ‘lockdown’ as might have been expected, except among older people. Replication of this study in other settings and investigating the potential benefits of more regular reviews or more intensive treatments for at-risk groups, are warranted

    Measurement invariance and differential item functioning of the PHQ-9 and GAD-7 between working age and older adults seeking treatment for common mental disorders

    Get PDF
    Background: The nine-item Patient Health Questionnaire (PHQ-9) and seven-item Generalised Anxiety Disorder (GAD-7) scale are widely used clinically and within research, and so it is important to determine how the measures, and individual items within the measures, are answered by adults of differing ages. This study sought to evaluate measurement invariance and differential item functioning (DIF) of the PHQ-9 and GAD-7 between working age and older adults seeking routine psychological treatment. // Methods: Data of working age (18–64 years old) and older (≄65) adults in eight Improving Access to Psychological Therapies (IAPT) services were used. Confirmatory factor analysis (CFA) was used to establish unidimensionality of the PHQ-9 and GAD-7, with multiple-group CFA to test measurement invariance and The Multiple Indicators, Multiple Causes Models approach to assess DIF. The employed methods were applied to a propensity score matched (PSM) sample in sensitivity analyses to control for potential confounding. // Results: Data from 166,816 patients (159,325 working age, 7491 older) were used to show measurement invariance for the PHQ-9 and GAD-7, with limited evidence of DIF and similar results found with a PSM sample (n = 5868). // Limitations: The localised sample creates an inability to detect geographical variance, and the potential effect of unmeasured confounders cannot be ruled out. // Conclusions: The findings support the use of the PHQ-9 and GAD-7 measures for working age and older adults, both clinically and in research settings. This study validates using the measures for these age groups to assess clinically significant symptom thresholds, and monitor treatment outcomes between them
    • 

    corecore